LQDA
NASDAQLiquidia Corporation
News · 26 weeks124-37%
2026-03-012026-08-23
Mix5790d
- Insider37(65%)
- SEC Filings11(19%)
- Other6(11%)
- Leadership1(2%)
- Analyst1(2%)
- Earnings1(2%)
Latest news
25 items- INSIDERChief Business Officer Adair Jason exercised 31,799 shares at a strike of $11.00 and sold $5,087,225 worth of shares (73,631 units at $69.09) as part of a pre-agreed trading plan, decreasing direct ownership by 19% to 174,606 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- SECSEC Form 144 filed by Liquidia Corporation144 - Liquidia Corp (0001819576) (Subject)
- INSIDERDirector Rielly-Gauvin Katherine exercised 55,182 shares at a strike of $2.54 and sold $4,087,435 worth of shares (55,182 units at $74.07) (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERChief Medical Officer Saggar Rajeev sold $5,972,206 worth of shares (79,534 units at $75.09) and exercised 50,000 shares at a strike of $3.73, decreasing direct ownership by 17% to 142,265 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- SECSEC Form 144 filed by Liquidia Corporation144 - Liquidia Corp (0001819576) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Liquidia CorporationSCHEDULE 13G/A - Liquidia Corp (0001819576) (Subject)
- SECSEC Form 10-Q filed by Liquidia Corporation10-Q - Liquidia Corp (0001819576) (Filer)
- SECLiquidia Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits8-K - Liquidia Corp (0001819576) (Filer)
- PRLiquidia Corporation Reports Second Quarter 2026 Financial ResultsYUTREPIA® (treprostinil) inhalation powder net product sales of approximately $170.4 million in the second quarter of 2026, up 31% from the first quarter of 2026Approximately 5,900 unique patient prescriptions and more than 5,000 patients treated between launch in June 2025 and July 31, 2026Recorded fourth consecutive quarter of increasing profitability, with net income of $74.7 million, adjusted EBITDA of $96.3 million and an increase in cash and cash equivalents of $61.4 million compared to the first quarter of 2026Progressing 10 clinical studies supporting YUTREPIA and L606 across known and new indications for inhaled treprostinil MORRISVILLE, N.C., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Li
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Liquidia CorporationSCHEDULE 13G/A - Liquidia Corp (0001819576) (Subject)
- INSIDERChief Accounting Officer Boyle Dana sold $140,048 worth of shares (1,600 units at $87.53) as part of a pre-agreed trading plan, decreasing direct ownership by 0.94% to 167,919 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERChief Business Officer Adair Jason sold $60,221 worth of shares (688 units at $87.53) as part of a pre-agreed trading plan, decreasing direct ownership by 0.32% to 216,438 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- PRLiquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026MORRISVILLE, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will report its second quarter 2026 financial results on Wednesday, August 12, 2026. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update. The webcast will be available on Liquidia’s website at https://liquidia.com/investors/events-and-presentations. A rebroadcast of the event will be available and archived for a period of one year at the same location. About
- INSIDERDirector Bloch Stephen M sold $17,786,409 worth of shares (200,000 units at $88.93) (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Bloch Stephen M sold $6,285,250 worth of shares (78,596 units at $79.97) (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERChief Human Resource Officer Krepp Sarah converted options into 3,179 shares and sold $562,361 worth of shares (7,864 units at $71.51) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 117,178 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERChief Development Officer Khindri Sanjeev sold $84,740 worth of shares (1,185 units at $71.51) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 65,947 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERCFO and COO Kaseta Michael converted options into 12,879 shares and sold $1,460,965 worth of shares (20,430 units at $71.51) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 345,805 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERChief Executive Officer Jeffs Roger sold $2,520,683 worth of shares (35,249 units at $71.51) as part of a pre-agreed trading plan and converted options into 28,167 shares, decreasing direct ownership by 0.62% to 1,130,426 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERChief Business Officer Adair Jason converted options into 10,251 shares and sold $562,289 worth of shares (7,863 units at $71.51) as part of a pre-agreed trading plan, increasing direct ownership by 1% to 217,126 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERGeneral Counsel Schundler Russell converted options into 10,168 shares and sold $1,053,926 worth of shares (14,738 units at $71.51) as part of a pre-agreed trading plan, decreasing direct ownership by 0.75% to 605,962 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERChief Medical Officer Saggar Rajeev converted options into 8,018 shares and sold $709,816 worth of shares (9,926 units at $71.51) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 171,799 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERChief Commercial Officer Moomaw Scott converted options into 7,466 shares and sold $682,142 worth of shares (9,539 units at $71.51) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 182,485 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERChief Accounting Officer Boyle Dana converted options into 3,179 shares and sold $643,740 worth of shares (9,002 units at $71.51) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 169,519 units (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
- INSIDERDirector Bloch Stephen M sold $6,051,170 worth of shares (75,000 units at $80.68) (SEC Form 4)4 - Liquidia Corp (0001819576) (Issuer)
LQDA FAQ
7 questionsWhat does Liquidia Corporation do?
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; and LIQ865, a sustained-release formulation of bupivacaine for the treatment of local post-operative pain. The company also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.Where does LQDA stock trade?
Liquidia Corporation (LQDA) is listed on NASDAQ.What sector and industry is LQDA in?
Liquidia Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Liquidia Corporation go public?
Liquidia Corporation (LQDA) completed its IPO in 2018.What are analysts saying about LQDA?
Liquidia Corporation has had 8 recent analyst actions on file. The most recent action was from BofA Securities: Neutral on 2026-06-29. Recent price targets range from $1300.00 to $4300.00.What companies are similar to LQDA?
Notable peers in the same industry include UTHR (United Therapeutics Corporation), TVTX (Travere Therapeutics Inc.), VCYT (Veracyte Inc.). Compare LQDA side-by-side with any of them on Quantisnow.How can I track LQDA on Quantisnow?
Quantisnow aggregates Liquidia Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LQDA to receive live email and push alerts on every new disclosure.